journal article·2022-09-14Open access

Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment

Lu Zhang, Ruonan Bo, Yi Wu, Longmeng Li, Zheng Zhu, Ai-Hong Ma, Wenwu Xiao, Yanyu Huang, Tatu Rojalin, Xingbin Yin, Chunping Mao, Fengyi Wang, Yongheng Wang, Hongyong Zhang, Kelmen E. Low, Kiana Lee, Yousif Ajena, Di Jing, Dalin Zhang, Christopher M. Baehr, Ruiwu Liu, Lei Wang, Yuanpei Li, Kit S. Lam

Nano Letters· Volume 22· Issue 17

Abstract

Immune checkpoint blockade (ICB) therapy has revolutionized clinical oncology. However, the efficacy of ICB therapy is limited by the ineffective infiltration of T effector (Teff) cells to tumors and the immunosuppressive tumor microenvironment (TME). Here, we report a programmable tumor cells/Teff cells bispecific nano-immunoengager (NIE) that can circumvent these limitations to improve ICB therapy. The peptidic nanoparticles (NIE-NPs) bind tumor cell surface α3β1 integrin and undergo in situ transformation into nanofibrillar network nanofibers (NIE-NFs). The prolonged retained nanofibrillar network at the TME captures Teff cells via the activatable α4β1 integrin ligand and allows sustained release of resiquimod for immunomodulation. This bispecific NIE eliminates syngeneic 4T1 breast cancer and Lewis lung cancer models in mice, when given together with anti-PD-1 antibody. The in vivo structural transformation-based supramolecular bispecific NIE represents an innovative class of programmable receptor-mediated targeted immunotherapeutics to greatly enhance ICB therapy against cancers.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Nanoplatforms for cancer theranostics · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry and Molecular Medicine, UC Davis NCI-designated Comprehensive Cancer Center, University of California Davis, Sacramento, California 95817, United States

Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China

CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China

Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California 95817, United States

Funding

National Cancer Institute · Ministry of Science and Technology of the People's Republic of China · National Institute of Dental and Craniofacial Research · National Institute of Biomedical Imaging and Bioengineering

References (36)

Show source-provided references
1. 10.1056/NEJMra170348110.1056/NEJMra1703481 ↗
2. 10.1038/nrc.2016.3610.1038/nrc.2016.36 ↗
3. 10.1038/labinvest.2017.2510.1038/labinvest.2017.25 ↗
4. 10.1200/EDBK_24083710.1200/EDBK_240837 ↗
5. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
6. 10.1039/C9CS00773C10.1039/C9CS00773C ↗
7. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
8. 10.1038/s41578-019-0108-110.1038/s41578-019-0108-1 ↗
9. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
10. 10.1126/sciadv.aay778510.1126/sciadv.aay7785 ↗
11. 10.1038/s41565-019-0626-410.1038/s41565-019-0626-4 ↗
12. 10.1021/acs.chemrev.8b0019510.1021/acs.chemrev.8b00195 ↗
13. 10.1002/anie.20181455210.1002/anie.201814552 ↗
14. 10.1021/acs.nanolett.8b0107110.1021/acs.nanolett.8b01071 ↗
15. 10.1126/sciadv.aaz410710.1126/sciadv.aaz4107 ↗
16. 10.1038/s41467-018-04255-z10.1038/s41467-018-04255-z ↗
17. 10.1186/s13550-016-0165-z10.1186/s13550-016-0165-z ↗
18. 10.1053/j.gastro.2019.10.03810.1053/j.gastro.2019.10.038 ↗
19. 10.1186/s13045-019-0740-710.1186/s13045-019-0740-7 ↗
20. 10.1002/adma.20160586910.1002/adma.201605869 ↗
21. 10.1038/nn96810.1038/nn968 ↗
22. 10.1038/nm78310.1038/nm783 ↗
23. 10.1038/nchembio79810.1038/nchembio798 ↗
24. 10.1126/scitranslmed.aan368210.1126/scitranslmed.aan3682 ↗
25. 10.1038/nrc323910.1038/nrc3239 ↗
26. 10.1126/science.aaa817210.1126/science.aaa8172 ↗
27. 10.1021/acs.nanolett.8b0309610.1021/acs.nanolett.8b03096 ↗
28. 10.1021/jacs.8b0808810.1021/jacs.8b08088 ↗
29. 10.1002/ange.20190775410.1002/ange.201907754 ↗
30. 10.1021/jp972337210.1021/jp9723372 ↗
31. 10.1038/nature1072010.1038/nature10720 ↗
32. 10.1126/sciadv.aaz898510.1126/sciadv.aaz8985 ↗
33. 10.1126/scitranslmed.aar191610.1126/scitranslmed.aar1916 ↗
34. 10.1038/nbt.337110.1038/nbt.3371 ↗
35. 10.1084/jem.2004193010.1084/jem.20041930 ↗
36. 10.1016/j.cell.2017.08.00410.1016/j.cell.2017.08.004 ↗